These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33533687)

  • 1. Differences in Bile Microbiology and Antibiotic Resistances between Liver Transplant Recipients and Non-Transplant Patients.
    Kang E; Suh SW; Lee SE; Choi YS; Choi SH; Lee BR; Choi Y; Jeong J
    Surg Infect (Larchmt); 2021 Sep; 22(7):741-751. PubMed ID: 33533687
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.
    Kaldas FM; Korayem IM; Russell TA; Agopian VG; Aziz A; DiNorcia J; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
    JAMA Surg; 2019 May; 154(5):431-439. PubMed ID: 30758485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenems versus Cephalosporin or Piperacillin-Tazobactam as Perioperative Antibiotic Prophylaxis in Liver Transplant Recipients with Model for End-Stage Liver Disease Scores of ≥30: A Retrospective Study in a Chinese Population.
    Zhang W; Chen Y; Zhang Y; Wang R; Wang W; Bai X; Liang T
    Infect Drug Resist; 2022; 15():4487-4494. PubMed ID: 35983301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Sarwar S; Koff A; Malinis M; Azar MM
    Transpl Infect Dis; 2020 Jun; 22(3):e13280. PubMed ID: 32216015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients.
    Kim HK; Park YK; Wang HJ; Kim BW; Shin SY; Lim SK; Choi YH
    Infect Chemother; 2013 Sep; 45(3):315-24. PubMed ID: 24396633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
    Mazur RD; Goldberg DS
    Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic selection based on microbiology and resistance profiles of bile from gallbladder of patients with acute cholecystitis.
    Suh SW; Choi YS; Choi SH; Do JH; Oh HC; Kim HJ; Lee SE
    Sci Rep; 2021 Feb; 11(1):2969. PubMed ID: 33536564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
    Rerknimitr R; Fogel EL; Kalayci C; Esber E; Lehman GA; Sherman S
    Gastrointest Endosc; 2002 Dec; 56(6):885-9. PubMed ID: 12447303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
    Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
    Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Microbial Profiles and Antibiotic Resistance Patterns in Patients with Biliary Tract Infection over a Six-Year Period.
    Zhao J; Wang Q; Zhang J
    Surg Infect (Larchmt); 2019 Sep; 20(6):480-485. PubMed ID: 31017560
    [No Abstract]   [Full Text] [Related]  

  • 17. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes.
    Freire MP; Soares Oshiro IC; Bonazzi PR; Guimarães T; Ramos Figueira ER; Bacchella T; Costa SF; Carneiro D'Albuquerque LA; Abdala E
    Liver Transpl; 2013 Sep; 19(9):1011-9. PubMed ID: 23744748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Sullivan T; Weinberg A; Rana M; Patel G; Huprikar S
    Transplantation; 2016 Sep; 100(9):1939-43. PubMed ID: 27379554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.